http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Abbott Increases Quarterly Dividend for 52nd Consecutive Year
-
Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3™ Heart Pump
-
Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes
-
Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes
-
Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology
-
Abbott (ABT) Granted FDA Approval of HPV Test to Run on Alinity m
-
Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV
-
Abbott and Damar Hamlin Team Up To Build Heart Health Community With New Heartmates Program
-
Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology
-
Abbott and Damar Hamlin Team Up to Build Heart Health Community with New HeartMates Program
-
Ninety-One Percent of Young Adults With Student Loans Say Financial Stress Is Impacting Their Wellness
-
Ninety-One Percent of Young Adults With Student Loans Say Financial Stress is Impacting Their Wellness -- Abbott Launches Blueprint of Award-Winning Program to Help Companies Tackle This Problem
-
Late-Breaking Data Show Esprit™ BTK Drug-Eluting Resorbable Scaffold Reduces Chronic Limb-Threatening Ischemia Progression Compared to the Standard of Care
-
Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves
-
Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
-
Abbott Hosts Conference Call for Third-Quarter Earnings
-
Abbott Completes Acquisition of Bigfoot Biomedical
-
Abbott Declares 399th Consecutive Quarterly Dividend
-
Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets
-
Abbott and WeightWatchers Connected App Experience is Now Available for People Living with Diabetes
-
Abbott (ABT) to Acquire Bigfoot Biomedical
-
Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes
-
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
-
Abbott (ABT) Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker
-
Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker
-
Abbott Hosts Conference Call for Second-Quarter Earnings
-
Abbott's FreeStyle Libre® 2 Receives National Reimbursement in France for All People with Diabetes Who Use Insulin¹
-
Abbott Declares 398th Consecutive Quarterly Dividend
-
Abbott, Real Madrid and the Real Madrid Foundation Band Together To ‘Beat Malnutrition’ Globally Through New Campaign
-
Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign
-
European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations
-
Abbott Unveils Late-Breaking Data Showing the World's First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints
-
Abbott (ABT) Receives FDA Approval for TactiFlex Ablation Catheter for Treatment of Abnormal Heart Rhythm
-
Abbott Receives FDA Approval for TactiFlex™ Ablation Catheter for Treatment of Abnormal Heart Rhythm
-
Abbott (ABT) Receives FDA Clearance for Assert-IQ Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term
-
Abbott Receives FDA Clearance for Assert-IQ™ Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term
-
Abbott (ABT) Granted FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain
-
Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options
-
Abbott Announces New Partnerships and Programs To Advance Its Diversity in Clinical Trials Initiative
-
Abbott Announces New Partnerships and Programs to Advance its Diversity in Clinical Trials Initiative
-
Abbott Completes Acquisition of Cardiovascular Systems, Inc.
-
Abbott's (ABT) Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients
-
Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients
-
Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change
-
Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change
-
Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business
-
Abbott (ABT) FreeStyle Libre Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries
-
Abbott's FreeStyle Libre® Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries
-
Abbott (ABT) Announces FDA Clearance of Reader for FreeStyle Libre 3 System
-
FDA Clears Reader for Abbott's FreeStyle Libre® 3 System
